Resources Repository
-
ArticlePublication 2023Cost-Effectiveness of Pharmacist Prescribing for Managing Hypertension
This study estimates the cost-effectiveness of implementing a pharmacist-prescribing intervention to improve blood pressure control …
This study estimates the cost-effectiveness of implementing a pharmacist-prescribing intervention to improve blood pressure control in the US. A cost-effectiveness analysis was conducted using a Markov model based on the pharmacist-prescribing intervention used in The Alberta Clinical Trial in Optimizing Hypertension (or RxACTION). Outcomes included cardiovascular (CV) events, end-stage kidney disease events, life years, quality-adjusted life years (QALYs), lifetime costs, and lifetime incremental cost-effectiveness ratio (ICER). Costs were based on reimbursement rates, published literature, national…
Cost-Effectiveness Analysis | North America | Mathematical Models | State-Transition | Chronic Disease/Risk | Clinical Care | Health/Medicine -
ArticlePublication 2023Cost-Effectiveness of Intensive vs. Standard Blood Pressure Control Among Older Patients
This economic analysis explored the cost-effectiveness of intensive vs standard blood pressure control in older …
This economic analysis explored the cost-effectiveness of intensive vs standard blood pressure control in older hypertensive patients between 60 and 80 years in China, the US, and the UK. Treatment outcome data from the Trial of Intensive Blood-Pressure Control in Older Patients with Hypertension (STEP trial) and different cardiovascular risk assessment models for a hypothetical cohort of STEP-eligible patients were used. Costs and utilities were obtained from published sources. A Markov model was used to…
Cost-Effectiveness Analysis | North America | Mathematical Models | Chronic Disease/Risk | Clinical Care -
ArticlePublication 2023Catalogues of EQ-5D-3L Health-Related Quality of Life Scores for 199 Chronic Conditions and Health Risks for Use in the UK & the U.S.
This study aimed to create UK and US EQ-5D-3L-based health-related quality of life (HRQoL) utility …
This study aimed to create UK and US EQ-5D-3L-based health-related quality of life (HRQoL) utility population catalogues for 199 chronic conditions using ICD-10 codes and health risks. It also sought to develop regression models to predict these utilities in other populations. Methods involved applying UK and US EQ-5D-3L value sets to responses from a Danish dataset, which combined national health survey data with national registers containing patient information on diagnoses, healthcare activities, and socio-demographics. Adjusted…
Preferences/Values | North America | Health Outcomes | Health/Medicine | Europe -
ArticlePublication 2023Cost-Effectiveness and Long-Term Savings of the Bright Bodies Intervention for Childhood Obesity
This study evaluates the cost-effectiveness of Bright Bodies, a family-based pediatric weight management intervention, using …
This study evaluates the cost-effectiveness of Bright Bodies, a family-based pediatric weight management intervention, using a microsimulation model projecting 10-year BMI trajectories of children with obesity. Data from a randomized controlled trial and follow-up study inform the model, which estimates the intervention's effect on BMI reduction and incremental costs compared to clinical control. Results indicate that Bright Bodies reduces BMI by 1.67 kg/m2 per year over 10 years, with an incremental cost of $360 per…
Cost-Effectiveness Analysis | North America | Microsimulation | Child/Nutrition | Health/Medicine -
ArticlePublication 2023New Type 2 Diabetes Microsimulation Model to Estimate Long-Term Health Outcomes, Costs, Cost-Effectiveness
This study presents a microsimulation model designed to estimate the health effects, costs, and cost-effectiveness …
This study presents a microsimulation model designed to estimate the health effects, costs, and cost-effectiveness of interventions for type 2 diabetes in the United States. Unlike existing models that rely on UK data, this model incorporates newly derived risk equations based on US studies, enhancing its applicability to the US context. The model features a highly modular architecture allowing for easy addition of new modules and interventions, facilitating policy decision-making. Internal validation showed good performance,…
Cost-Effectiveness Analysis | North America | Microsimulation | Chronic Disease/Risk | Health/Medicine -
ArticlePublication 2023Evaluation of Diversity of Clinical Trials Informing Health Technology Assessments in the United States: A 5-Year Analysis of Institute for Clinical and Economic Review Assessments
The study assessed the diversity of clinical trials informing assessments by the Institute for Clinical …
The study assessed the diversity of clinical trials informing assessments by the Institute for Clinical and Economic Review (ICER) over five years (2017-2021). It conducted a cross-sectional analysis of 208 pivotal trials across 31 conditions. Findings revealed inadequate representation of racial/ethnic minorities and older adults, with Blacks/African Americans, American Indians/Alaska Natives, and Hispanics/Latinos being notably underrepresented. Whites, Asians, and Native Hawaiian/Other Pacific Islanders were adequately represented. US-based trials better represented Blacks/African Americans and Hispanics/Latinos but…
Technology Assessment | North America | Evidence Synthesis | Health/Medicine -
ArticlePublication 2023Estimating the US Baseline Distribution of Health Inequalities Across Race, Ethnicity, Geography for Equity-Informative CEA
This study addresses disparities in health outcomes among racial and ethnic groups in the United …
This study addresses disparities in health outcomes among racial and ethnic groups in the United States using Bayesian models to handle suppressed mortality data. By linking multiple US data sets, it demonstrates significant variations in life expectancy, disability-free life expectancy, and quality-adjusted life expectancy based on race, ethnicity, and geographic location. Results show that disparities persist and widen with age, especially between the best-off and worst-off subgroups in socially vulnerable counties. Life expectancy, disability-free life…
Cost-Effectiveness Analysis | North America | Health Outcomes | Social Determinants | Health/Medicine -
ArticlePublication 2023Calibration and Validation of the Colorectal Cancer and Adenoma Incidence and Mortality (CRC-AIM) Microsimulation Model Using Deep Neural Networks
This study explores the efficacy of machine learning (ML)-based emulators in calibrating complex microsimulation models, …
This study explores the efficacy of machine learning (ML)-based emulators in calibrating complex microsimulation models, using the Colorectal Cancer (CRC)-Adenoma Incidence and Mortality (CRC-AIM) model as a case study. ML algorithms, including deep neural networks (DNN), were trained and compared using data generated from the CRC-AIM model to predict various outcomes. The DNN outperformed other algorithms and efficiently predicted outcomes, reducing computational burden significantly. The calibrated CRC-AIM model demonstrated cross-model validity against established CISNET models…
Calibration/Validation | North America | Microsimulation | Chronic Disease/Risk | Health/Medicine -
ArticlePublication 2022Estimated Transmission Outcomes and Costs of SARS-CoV-2 Diagnostic Testing, Screening, and Surveillance Strategies Among a Simulated Population of Primary School Students
In the wake of the COVID-19 pandemic's significant educational disruptions, the U.S. government allocated $10 …
In the wake of the COVID-19 pandemic's significant educational disruptions, the U.S. government allocated $10 billion in March 2021 for testing in schools. The study aimed to analyze the costs and benefits of different COVID-19 testing strategies, particularly focusing on full-time, in-person elementary and middle school education. Utilizing an updated agent-based network model, the study simulated transmission scenarios in schools, considering various testing strategies ranging from diagnostic testing (test-to-stay) to reduce symptom-based isolations, routine screening…
Cost-Effectiveness Analysis | North America | Test Performance | Mathematical Models | Infectious Diseases | Clinical Care | Health/Medicine | Science/Technology